Statistical Learning as a Predictor of Attention Bias Modification Outcome

NCT03424967 | Completed

• 1 other identifier: TAU-SL
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

This study examines whether the ability to extract statistical properties from the environment among treatment-seeking patients with social anxiety disorder can predict therapeutic response to attention bias modification (ABM), namely, reduction in symptoms of social anxiety following ABM therapy.

Conditions

Social Anxiety Disorder

Keywords

attention-bias modification; statistical learning; social anxiety disorder; treatment outcome

Outcome Measures

Primary Outcomes (1)

• The Liebowitz Social Anxiety Scale (LSAS) - Diagnostic Interview scores

  The Liebowitz Social Anxiety Scale is a clinician-rated inventory consisting of 24 items describing socially relevant situations. Each situation is rated in relation to the past week on two sub-scales ranging 0-3: level of fear and level of avoidance experienced in response to these situations. Item scores are summed to a total score ranging 0-144

  1-2 weeks after treatment completion

Secondary Outcomes (1)

• The Social Phobia Inventory scores

  1-2 weeks after treatment completion

Study Arms (1)

ABM therapy

EXPERIMENTAL

The attention bias modification treatment comprises of six computerized sessions, twice a week, in purpose of modulate biases in attention for threat stimuli.

Behavioral: ABM

Interventions

ABM BEHAVIORAL

Participants are trained with a dot-probe task including angry-neutral faces. In 80% of trials the probe appears in place of the neutral face, and in 20% of trials in place of the angry face.

Also known as: attention bias modification

ABM therapy

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• a signed consent form
• a primary diagnosis of social anxiety disorder
• an age of 18-65

You may not qualify if:

• any history or present diagnosis of psychosis
• high risk for harm to self or others
• concurrent posttraumatic stress disorder, eating disorder, or bipolar disorder
• a diagnosis of a neurological disorder (i.e., epilepsy, brain injury)
• drug or alcohol misuse
• a pharmacological treatment that is not stabilized in the past 3 months
• any concurrent psychotherapy

Sponsors & Collaborators

• Tel Aviv University: lead

Study Sites (1)

Tel Aviv University

Tel Aviv, 6997801, Israel

Location

MeSH Terms

Conditions

Phobia, Social

Condition Hierarchy (Ancestors)

Phobic Disorders; Anxiety Disorders; Mental Disorders

Study Officials

• Yair Bar-Haim, PhD

  Tel Aviv University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: February 1, 2018
• First Posted: February 7, 2018
• Study Start: August 2, 2016
• Primary Completion: June 12, 2017
• Study Completion: June 12, 2017
• Last Updated: February 7, 2018

Record last verified: 2018-02

Data Sharing

• IPD Sharing: Will not share

Locations

IL (1)